(Q43975147)

28 November 2017

title

Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis (English)

1 reference

28 November 2017

0 references

12

Elie Azoulay

1 reference

28 November 2017

11

Benoît Schlemmer

1 reference

28 November 2017

2

Virginie Lemiale

1 reference

28 November 2017

6

Emmanuel Canet

1 reference

28 November 2017

10

Eric Mariotte

1 reference

28 November 2017

Gaston Burghi

1

1 reference

28 November 2017

Amélie Seguin

3

1 reference

28 November 2017

Jérôme Lambert

4

1 reference

28 November 2017

Claire Lacroix

5

1 reference

28 November 2017

Anne-Sophie Moreau

7

1 reference

28 November 2017

Patricia Ribaud

8

1 reference

28 November 2017

David Schnell

9

1 reference

28 November 2017

publication date

25 August 2011

1 reference

28 November 2017

published in

Intensive Care Medicine

1 reference

28 November 2017

volume

37

1 reference

28 November 2017

issue

10

1 reference

28 November 2017

page(s)

1605-1612

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-011-2344-8

28 November 2017

exact match

0 references

cites work

The prognosis of acute respiratory failure in critically ill cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Factors associated with overall and attributable mortality in invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Fungal infections in leukemia patients: how do we prevent and treat them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Diagnostic strategy in cancer patients with acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

[Diagnostic strategy for acute respiratory failure in patients with haematological malignancy]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Changes in causes of death over time after treatment for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

National questionnaire survey on what influences doctors' decisions about admission to intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Contribution of Galactomannan Antigen Detection in BAL to the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematologic Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-011-2344-8

Clinical risk factors for invasive aspergillosis

21 January 2018

1 reference

12 December 2020

Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support

1 reference

12 December 2020

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

1 reference

12 December 2020

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

1 reference

12 December 2020

Discrimination between invasive pulmonary aspergillosis and pulmonary lymphoma using CT

1 reference

12 December 2020

10.1007/S00134-011-2344-8

Identifiers

DOI

1 reference

28 November 2017

1 reference